Evidence map›Paper›PMID 35311590›Full record

ArticleMicrobiology spectrum2022

Inflammatory Endotype-Associated Airway Resistome in Chronic Obstructive Pulmonary Disease.

Xinzhu Yi, Yanjun Li, Haiyue Liu, Xiaomin Liu, Junhao Yang, Jingyuan Gao, Yuqiong Yang, Zhenyu Liang, Fengyan Wang, Dandan Chen and 7 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Multidrug-resistantERJ open research · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 4 countries.

Xinzhu Yi *Institute of Ecological Sciences, School of Life Sciences, South China Normal University, Guangzhou, China.
Yanjun Li *Emergency Department, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, China.
Haiyue Liu *Xiamen Key Laboratory of Genetic Testing, Department of Laboratory Medicine, the First Affiliated Hospital of Xiamen University, Xiamen, China.
Xiaomin LiuInstitute of Ecological Sciences, School of Life Sciences, South China Normal University, Guangzhou, China.
Junhao YangInstitute of Ecological Sciences, School of Life Sciences, South China Normal University, Guangzhou, China.
Jingyuan GaoInstitute of Ecological Sciences, School of Life Sciences, South China Normal University, Guangzhou, China.
Yuqiong YangFirst Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou, China.
Zhenyu LiangFirst Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou, China.
Fengyan WangFirst Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou, China.
Dandan ChenKey Laboratory of Shenzhen Respiratory Diseases, Institute of Shenzhen Respiratory Diseases, Shenzhen People's Hospital, Shenzhen, China.
Lingwei WangKey Laboratory of Shenzhen Respiratory Diseases, Institute of Shenzhen Respiratory Diseases, Shenzhen People's Hospital, Shenzhen, China.
Weijuan ShiFirst Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou, China.
David C L LamDepartment of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.
Martin R StampfliDepartment of Medicine, Firestone Institute of Respiratory Health at St. Joseph's Healthcare, McMaster Universitygrid.25073.33, Hamilton, Ontario, Canada.
Paul W JonesInstitute for Infection and Immunity, St George's, University of London, London, United Kingdom.
Rongchang ChenFirst Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou, China.
Zhang WangInstitute of Ecological Sciences, School of Life Sciences, South China Normal University, Guangzhou, China.ORCID 0000-0003-1278-8950
First Affiliated Hospital of Guangzhou Medical University · CNSouth China Normal University · CNShenZhen People’s Hospital · CNFirst Affiliated Hospital of Xiamen University · CNShenzhen Pingle Orthopedic Hospital · CNSt George's, University of London · GBSt. Joseph’s Healthcare Hamilton · CAUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance is a global concern in chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD). The collection of antibiotic resistance genes or resistome in human airways may underlie the resistance. COPD is heterogeneous, and understanding the airway resistome in relation to patient phenotype and endotype may inform precision antibiotic therapy. Here, we characterized the airway resistome for 94 COPD participants at stable disease. Among all demographic and clinical factors, patient inflammatory endotype was associated with the airway resistome. There were distinct resistome profiles between patients with neutrophilic or eosinophilic inflammation, two primary inflammatory endotypes in COPD. For neutrophil-predominant COPD, the resistome was dominated by multidrug resistance genes. For eosinophil-predominant COPD, the resistome was diverse, with an increased portion of patients showing a macrolide-high resistome. The differential antimicrobial resistance pattern was validated by sputum culture and

Indexed as

AsthmaPulmonary Disease, Chronic ObstructiveAnti-Bacterial AgentsEosinophilsHumansInflammationAnti-Bacterial Agentsairway microbiomeantibiotic resistanceCOPDinflammationmacrolides

Identifiers

PMID35311590
PMCPMC9045194
OpenAlexW4220734220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.